home / stock / ebs / ebs news

EBS News and Press, Emergent Biosolutions Inc. From 09/19/25

Stock Information
Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com
Menu
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...
EBS - Emergent Biosolutions secures $29M in MCM product orders from international government partner

2025-09-19 08:39:09 ET More on Emergent Biosolutions Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally Emergent BioSolutions secures $17M contract modification for oral suspension TEMBEXA Mpox in Africa is no longer a global health emergency, WHO chie...
EBS - Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured new purchase orders from an international government partner for a multi-product supply agreement valued at $29 million (USD). The orders span several product offerings with...

EBS - Emergent BioSolutions secures $17M contract modification for oral suspension TEMBEXA

2025-09-15 08:54:29 ET More on Emergent Biosolutions Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful Mpox in Africa is no longer a global health emergency, WHO chief s...

EBS - Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Prepare...
EBS - Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

GAITHERSBURG, Md., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that a contract modification has been executed in the amount of $56 million to supply ACAM2000 ® , (Smallpox and Mpox (Vaccinia) Vaccine, Live) to the U.S. government. D...

EBS - Mpox in Africa is no longer a global health emergency, WHO chief says

2025-09-06 11:04:59 ET More on Bavarian Nordic, Abbott, etc. Bavarian Nordic A/S 2025 Q2 - Results - Earnings Call Presentation Bavarian Nordic A/S (BVNKF) Q2 2025 Earnings Call Transcript Tonix Pharmaceuticals Soars, Then Sinks: What's Next After Tonmya's Approval (...

EBS - Emergent Biosolutions awarded $30 million contract modification for CYFENDUS

2025-09-02 08:08:55 ET More on Emergent Biosolutions Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful ...
EBS - Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

GAITHERSBURG, Md., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $30 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Prepare...

EBS - Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

Pro Football Hall of Famer and Ready to Rescue campaign spokesperson, Emmitt Smith, and Release Recovery Founder/CEO, Zac Clark, plan to visit several U.S. college campuses to educate on opioid emergency preparedness New sponsorship of Mobilize Recovery's “Campus Surge” init...

EBS - Emergent BioSolutions to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences: Wells Fargo 20 th Annual Healthcare Conference Se...
Previous 10 Next 10